Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Haibo Xing

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8970-8042; OpenAlex author ID A5036149545. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 5

  1. Corrigendum to "Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells". Co-author DOI 10.1155/2022/9767389↗
  2. Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis. First author DOI 10.1007/s12032-020-1339-0↗
  3. Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized … Co-author DOI 10.7150/jca.26672↗
  4. Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. Co-author DOI 10.1155/2018/3195025↗
  5. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Co-author DOI 10.1155/2018/8704751↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mengting Tong · 4 shared papers, 2018–2022 · strength 0.46
  2. Da Li · 3 shared papers, 2018–2022 · strength 0.36
  3. Yanling Wang · 2 shared papers, 2018–2019 · strength 0.19
  4. Da Li · 1 shared paper, 2020 · strength 0.15
  5. Wei Wang · 1 shared paper, 2020 · strength 0.15
  6. Da Li · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.